<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240214061006N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-29</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>A study on the effect of vaginal aloe vera cream on the sexual function and sexual satisfaction of  Post- menopausal women</public_title>
      <acronym></acronym>
      <scientific_title>A study on the effect of vaginal aloe vera cream on the sexual function and sexual satisfaction of  Post- menopausal women</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-04-02</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>100</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/75570</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Used, Assignment: Other, Purpose: Treatment, Other design features: Research units will be divided into intervention and control groups. The intervention group will use aloe vera vaginal cream and the control group will use placebo for 2 months, Randomization description: The research units will be divided into two intervention and control groups in a simple random manner using Excel software and random number function. The list of people will be determined before the start of the study and people will be placed in each of the groups in order of entry. In this way, the researcher will be unaware of the type of group of each person before starting the intervention, Blinding description: In this research, the researcher, the participants and the data analyst will not know which group (intervention or control) each participant is in (at the beginning of the research, the participant will be informed that he may be in any of the intervention or control groups). be controlled), so that with simple random method and random number function, it will be determined that according to the participant number (which will be assigned according to the order of entry into the research) that participant will be placed in which group A or B, but Until the end of the research, it will not be clear which group A or B is intervention or control.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: sexual function. Condition 2: sexual satisfaction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this research, aloe vera plant will be prepared from the greenhouse around Tehran and after confirming the scientific name, at the Faculty of Pharmacy of Shahid Beheshti University of Medical Sciences and Health Services, its leaves will be separated and extracted with ethanol. It is inserted into the base of the vaginal cream and it will be prepared in the form of aloe vera vaginal cream, and it will be autoclaved after preparation. which will be consumed vaginally by the research samples for 2 weeks, every night and then for the next 6 weeks, three nights a week and during sexual intercourse, 7 grams each time with an applicator. Intervention 2: Control group: In this research, the vaginal cream placebo will be based on vaginal cream without any effective ingredients (including cetostearyl alcohol, petroleum gel, glycerin, water, mineral oil, protective and antioxidant substances, etc.) Shahid Beheshti's health care services have been prepared and after preparation, it will be autoclaved, which in terms of shape, smell, color, size and amount is completely similar to vaginal aloe vera cream, which is applied every night for 2 weeks and then three nights a week for the next 6 weeks. And during sexual intercourse, 7 grams will be taken vaginally with an applicator.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Neda Khalaji</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Gohardasht, moazen blvd, north pirozi ave, bostan19, number15</address>
        <city>Karaj</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3147834579</zip>
        <telephone>+98 26 3431 8371</telephone>
        <email>khalajineda3@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>dr.Masoumeh simbar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Vali Asr St., intersection of Ayat A... Hashemi Rafsanjani Highway, in front of Shahid Rajaee Heart Hospital, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1996835119</zip>
        <telephone>+98 21 8865 5376</telephone>
        <email>msimar@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 45-65 years
Experience of at least 12 months of amenorrhea
Natural menopause (absence of menopause following surgery, absence of premature menopause (at the age of less than 40))
Postmenopausal women who are in their first 10 years of menopause.
Having a husband and having sex with her
Lack of sexual impotence in the husband (according to the woman)
Having symptoms of vaginal dryness, dyspareunia and itching
Not taking herbal hormonal drugs containing phytoestrogens or hormonal supplements in any form
Being literate in reading and writing
Not using herbal or chemical drugs affecting sexual function
No history of hysterectomy and mastectomy
A maximum of five natural births
Not having genital infections (according to the woman)
BMI less than 30
No stressful event has occurred in the last 6 months (death or illness of close relatives, major change in living situation) in any of the couples.
According to the wife, there are no mental problems (illness under observation or treatment by a doctor) in any of the couples.
Absence of disease affecting sexual function</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>65 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria></exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this research, aloe vera plant will be prepared from the greenhouse around Tehran and after confirming the scientific name, at the Faculty of Pharmacy of Shahid Beheshti University of Medical Sciences and Health Services, its leaves will be separated and extracted with ethanol. It is inserted into the base of the vaginal cream and it will be prepared in the form of aloe vera vaginal cream, and it will be autoclaved after preparation. which will be consumed vaginally by the research samples for 2 weeks, every night and then for the next 6 weeks, three nights a week and during sexual intercourse, 7 grams each time with an applicator.</i_keyword>
      <i_keyword>Control group: In this research, the vaginal cream placebo will be based on vaginal cream without any effective ingredients (including cetostearyl alcohol, petroleum gel, glycerin, water, mineral oil, protective and antioxidant substances, etc.) Shahid Beheshti's health care services have been prepared and after preparation, it will be autoclaved, which in terms of shape, smell, color, size and amount is completely similar to vaginal aloe vera cream, which is applied every night for 2 weeks and then three nights a week for the next 6 weeks. And during sexual intercourse, 7 grams will be taken vaginally with an applicator.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Sexual function score in females sexual function index questionnaire. Timepoint: At the beginning of the study and 4 and 8 weeks after starting to use vaginal aloe vera cream. Method of measurement: females sexual function index questionnaire.</prim_outcome>
      <prim_outcome>Sexual satisfaction score in Hudson's sexual satisfaction questionnaire. Timepoint: At the beginning of the study and 4 and 8 weeks after starting to use vaginal aloe vera cream. Method of measurement: Hudson's sexual satisfaction questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-02-11</approval_date>
        <contact_name>research ethics committess of school of pharmacy and nursing and midwifery--shahid beheshti universi</contact_name>
        <contact_address>Tehran, Vali Asr St., intersection of Ayat A... Hashemi Rafsanjani Highway, in front of Shahid Rajaee Heart Hospital, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
